2014-2015 Flu Vaccine Effectiveness

Edward Belongia, M.D., director of the Center for Clinical Epidemiology and Population Health, was featured in numerous stories about the effectiveness of this year’s flu vaccine. Along with media interviews ( Marshfield News HeraldWSAW ) Dr. Belongia served as an expert source for the Canadian Press, which distributes news stories throughout Canada. For more information pertaining to CDC’s interim report on this year’s flu vaccine effectiveness, visit ABC News and the CDC Morbidity and Mortality Weekly Report

Grant received by CCEPH to raise awareness for HPV vaccination

CCEPH researchers received a $620,000 grant from CDC to help educate the public about human papilloma virus and to improve HPV vaccination rates among adolescents.

CCEPH receives grant to study MMR vaccine

A $440,000 federal grant will support CCEPH researchers’ study of long-term effectiveness of a third dose of Measles, Mumps and Rubella (MMR) vaccine, as scientists work to better protect against mumps.

CCEPH Researcher Appointed to ACIP 

Edward Belongia, MD, Director of CCEPH was appointed as a voting member to the Advisory Committee on Immunization Practices (ACIP). ACIP is a group of 15 medical and public health experts who develop recommendations on how to use vaccines to control diseases in the United States.

Ebola 101: Separating Fact from Fiction (October 30, 2014)

So what are the facts? Should we get ready for an Ebola epidemic in the United States? Edward Belongia, MD, Director of CCEPH, infectious disease epidemiologist and former CDC Epidemic Intelligence Service Officer provides a brief review of what we know and don’t know.

National Obesity Treatment Study in Rural Communities

CCEPH researchers and Marshfield Clinic doctors are looking for new, more effective ways to treat obesity in rural communities as part of a 5-year, $10 million national study. (July 2014)

CCEPH researchers' study finds prior flu season vaccines may provide residual protection (October 1, 2014)

Influenza vaccines given in prior years may provide protection against the flu for more than one year, according to a study published online Monday, Sept. 29, in the journal Clinical Infectious Diseases.

Marshfield Clinic Helps CDC with This Year's Flu Vaccine (January 30, 2014)

Doctors say we are in the heat of flu season; if you're going to get vaccinated, now is the perfect time.
Edward Belongia, MD was interviewed on the respected Influenza research being conducted right here in Marshfield. As stated in the article, "So far, they’ve enrolled more than 500 people in the study at Marshfield, and about 45 percent have tested positive for the flu."
Efforts continue with the study team and as Ed was quoted, "It’s still not too late, but don’t wait to get vaccinated."

H1N1 reappears as main flu strain (January 4, 2014)

Edward Belongia, MD was quoted in the Marshfield News Herald regarding the research on this year’s flu season. In January he stated, "In terms of number of cases, it’s still relatively low, but we’re nowhere near the peak of the season." A typical flu season begins in December and continues through to February. For the 2013-14 season there were reports of Flu increasing in late November.

Do Vitamins A, E and Zinc Affect Immunity in Well-Nourished Seniors? (December 19, 2013)

Vitamins A, E, and Zinc have been identified as having an effect on the immune system. Maria Sundaram, MSPH worked in collaboration on the investigation of this relationship due to the elderly population being at risk for vitamin deficiencies and influenza.